The Inflation Reduction Act caps Medicare beneficiaries’ annual out-of-pocket costs for prescription drugs covered by Medicare Part D at $2,000 per year starting in 2025.
Cap Medicare Part D out-of-pocket prescription drug costs at $2,000 per year starting in 2025.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
Congress.gov lists H.R. 5376 as Public Law 117-169. Its summary says Sec. 11201 caps Medicare Part D annual out-of-pocket spending at $2,000 in 2025, with annual adjustments thereafter.
legacy_unverified · Source version not recorded · locator unknown
The House Clerk roll call for H.R. 5376 shows the motion passed 220-207 and records Sean Casten, Democrat of Illinois, voting Yea.
Assessments
The promised policy was enacted in the Inflation Reduction Act, Public Law 117-169, which capped Medicare Part D annual out-of-pocket prescription drug costs at $2,000 beginning in 2025. Sean Casten was a sitting U.S. Representative and voted yea on H.R. 5376, giving him direct legislative credit for materially advancing the enacted bill. Because the substantive cap takes effect in 2025 after enactment, timing is best treated as later_term.